Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McCormack

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Australasian Journal of Dermatology|March 9, 2023
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer CentreFriyana K Bhabha, Christopher McCormack, Belinda A Campbell, et al.
Cancers|November 14, 2019
Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis FungoidesBelinda A Campbell, Gail Ryan, Christopher McCormack, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2025
Radiotherapy dose-response of mycosis fungoides with large cell transformationMartin J Higgins, Philippa Johnstone, H Miles Prince, et al.
Blood|August 31, 2019
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndromeCrystal Gao, Christopher McCormack, Carrie van der Weyden, et al.
Blood|October 23, 2014
Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapyCharlotte F M Hughes, Amit Khot, Christopher McCormack, et al.
The Journal of Investigative Dermatology|December 26, 2025
Evaluation of clonality in lentigo malignaSophie Soyeon Lim, Peinan Zhao, Nicholas C Wong, et al.
The Australasian Journal of Dermatology|December 28, 2020
Mycosis fungoides and Sézary syndrome: Australian clinical practice statementFriyana K Bhabha, Christopher McCormack, Jillian Wells, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Australasian Journal of Dermatology|March 9, 2023
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer CentreFriyana K Bhabha, Christopher McCormack, Belinda A Campbell, et al.
Cancers|November 14, 2019
Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis FungoidesBelinda A Campbell, Gail Ryan, Christopher McCormack, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2025
Radiotherapy dose-response of mycosis fungoides with large cell transformationMartin J Higgins, Philippa Johnstone, H Miles Prince, et al.
Blood|August 31, 2019
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndromeCrystal Gao, Christopher McCormack, Carrie van der Weyden, et al.
Blood|October 23, 2014
Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapyCharlotte F M Hughes, Amit Khot, Christopher McCormack, et al.
The Journal of Investigative Dermatology|December 26, 2025
Evaluation of clonality in lentigo malignaSophie Soyeon Lim, Peinan Zhao, Nicholas C Wong, et al.
The Australasian Journal of Dermatology|December 28, 2020
Mycosis fungoides and Sézary syndrome: Australian clinical practice statementFriyana K Bhabha, Christopher McCormack, Jillian Wells, et al.
Pageof 4